Scholar Rock’s stock price increased by 362% after the company announced data from the Phase III SAPPHIRE trial of ...

Both had used methamphetamine before dying from an increasingly dangerous mix of soaring temperatures and stimulants. Meth is showing up more often as a factor in the deaths of people who died ...

Phase 3 findings could position the biotech’s therapy to become part of a “new standard” for SMA, its CEO said, while boosting research into whether it can preserve muscle in people with obesity.

The biotech company Scholar Rock reported Monday that its experimental ... paving the way for the likely approval of the drug. In a year-long Phase 3 trial, the company tested the drug, called ...

Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a ...

The lead singer of rock band The Alarm is in remission from an aggressive cancer thanks to an NHS drug trial. Mike Peters had been forced to cancel a US tour earlier this year after being ...

A Rock Island man with a history of drug trafficking convictions has been sentenced to 17½ years in federal prison after pleading guilty to conspiring to distribute meth and marijuana in the Quad ...

Policymakers in California embrace a proven but unorthodox treatment for meth and cocaine addiction: Give people gift cards ...

(Reuters) -Scholar Rock's experimental drug achieved its main target in a late-stage trial for spinal muscular atrophy, the biotech company said on Monday, sending its shares soaring more than 300 ...

A phase 3 trial of Scholar Rock’s spinal muscular atrophy (SMA) candidate has hit its primary endpoint, sparking a 200%-plus ...

Sum 41's Deryck Whibley accuses former manager Greig Nori of sexual and verbal abuse in his memoir 'Walking Disaster'.

A regimen of Scholar Rock’s drug, apitegromab ... that causes progressive muscular weakness and in its most severe form can be lethal in infants. Since then, regulators have approved a gene ...